Addex Therapeutics Ltd. Stock: price and insider trades · United States

Addex Therapeutics Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 22 October 2026, brought 14 filings signed by 7 insiders.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Compared with its exchange (5,462 companies, median 28 filings), a count of 14 filings is below the norm.

There has been no open-market purchase by an insider of Addex Therapeutics Ltd. for at least a year. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade.

Other companies in the same sector with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Vivos Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.